+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Dasatinib: pulmonary arterial hypertension. French data



Dasatinib: pulmonary arterial hypertension. French data



Prescrire International 20(120): 241-241




(PDF emailed within 1 workday: $29.90)

Accession: 052448405

Download citation: RISBibTeXText

PMID: 21970091


Related references

Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature. Medicine 95(39): E4911-E4911, 2016

Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry. International Journal of Cardiology 172(3): 561-567, 2015

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension. Pulmonary Circulation 7(4): 803-807, 2017

FRI0299Pulmonary Arterial Hypertension in Idiopathic Inflammatory Myopathies: Data from The French Pulmonary Hypertension Registry and Review of The Literature. Annals of the Rheumatic Diseases 75(Suppl 2): 543.2-543, 2016

First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension. European Respiratory Journal, 2018

Treatment for pulmonary arterial hypertension under the new French hospital financing system. Recommendations of the Pulmonary Vascular Diseases Working Group of the French Society of Pulmonary Medicine. Presse Medicale 34(19 Pt 2): 1456-1464, 2005

Dasatinib-Induced Pulmonary Arterial Hypertension. British Journal of Clinical Pharmacology, 2018

Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 125(17): 2128-2137, 2012

Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition. European Respiratory Journal 42(3): 869-870, 2014

Reversible dasatinib-related pulmonary arterial hypertension in a CML patient. Japanese Journal of Clinical Hematology 57(5): 618-623, 2016

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia. Cancer Research and Treatment 47(4): 937-942, 2015

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report. Journal of Medical Case Reports 11(1): 362-362, 2017

Dasatinib-induced pulmonary arterial hypertension - A rare late complication. Journal of Oncology Pharmacy Practice 1078155217753740-1078155217753740, 2018

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib. American Journal of Hematology 90(11): 1060-1064, 2016

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy. Case Reports in Cardiology 2018: 3895197-3895197, 2018